Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The National Lipid Association and PlatformQ Health Partner on CME Series Aimed at Reducing CVD Risk
  • USA - English
  • USA - English


News provided by

PlatformQ Health

Mar 22, 2017, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Michael J. Blaha, MD, MPH <br />Preventive Cardiology<br /> John Hopkins University
Michael J. Blaha, MD, MPH
Preventive Cardiology
John Hopkins University

The lipid-lowering field is evolving at an ever-accelerating rate. With new studies at nearly every major meeting, clinicians need succinct summaries of the latest evidence and how to apply it in their practice.

Post this

Boston, MA (PRWEB) March 22, 2017 -- High cholesterol — particularly a high level of low-density lipoprotein cholesterol (LDL-C) — is a main risk factor for developing cardiovascular disease (CVD), the number one cause of death in the United States. Treatment with statins has been shown to effectively lower LDL-C, but not for everyone. About 70% of patients with elevated LDL-C levels go untreated due to statin resistance, statin intolerance, familial hypercholesterolemia not well controlled on statins and nonadherence to statin treatment. For these patients, a newer class of injectable drugs, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, represents one of the most promising strategies.

To help educate clinicians on PCSK9 inhibitors and CVD risk reduction, the National Lipid Association and PlatformQ Health are partnering to produce a two-part online series airing on CardioCareLive.com.

Part 1 - The Emerging Role of PCSK9 Inhibitors and CV Risk Reduction
Live: Tuesday, April 11, 2017 2:00 PM - 3:00 PM EST

Part 2 - CVD and PCSK9 Inhibitors: Analyzing the Outcome Studies and Understanding Their Implications
Live: Tuesday, May 23, 2017 11:00 AM - 12:00 PM EST

CME credit provided by the National Lipid Association.
These activities have been approved for AMA PRA CATEGORY 1 CREDIT™.
These activities are eligible for ACPE and ANCC credit.

Clinicians can Register Here for the Series

Speakers:

  • Michael J. Blaha, MD, MPH; Director of Clinical Research, Ciccarone Center for the Prevention of Heart Disease; Assistant Professor of Medicine, Johns Hopkins University
  • Michael Miller, MD, FACC, FAHA; Professor of Cardiovascular Medicine, Epidemiology & Public Health; University of Maryland School of Medicine
  • Marc S. Sabatine, MD, MPH; Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine, Brigham and Women’s Hospital; Professor, Harvard Medical School

Featuring a panel of experts live-streamed through PlatformQ Health’s virtual learning channel CardioCareLive.com, each session includes an in-depth slide presentation, real-time Q&A and interactive polling. “PlatformQ Health always aims to partner with trusted organizations like the National Lipid Association to ensure our programs have the most positive impact possible,” says Robert Rosenbloom, CEO of PlatformQ Health. “We are especially honored to work with NLA to support clinicians treating such a deadly and far-reaching condition as cardiovascular disease.”

The series provides an accessible and timely means for clinicians to stay abreast of changing treatment options as well as the recommendations of the most current guidelines on their optimal use. “The lipid-lowering field is evolving at an ever-accelerating rate,” says speaker Michael J. Blaha, MD. “With new studies at nearly every major meeting, clinicians need succinct summaries of the latest evidence and how to apply it in their practice.” Improved knowledge of the updated guidelines and the benefits and risks of newer therapies will provide clinicians with the tools to select the optimal LDL-C-lowering regimens, address concerns, and improve adherence, to more effectively lower cardiovascular risk in their patients.

Topics of Interest

  • Treatment options beyond statins to decrease lipid-related CV risk in patients with hypercholesterolemia
  • Newer therapeutic options for patients with familial hypercholesterolemia
  • Pharmacological action of PCSK9 inhibitors and their role in decreasing risk of cardiovascular disease
  • Recent efficacy and safety clinical trial data from PCSK9 inhibitor cardiovascular outcomes trials

About PlatformQ Health
PlatformQ Health is the leading provider of live online medical education events, with 15 websites dedicated to different therapeutic areas. Their unique education platform allows physicians and other healthcare professionals to connect online from any computer, learn about the latest treatments options, and engage in real-time Q&A with top faculty.

About National Lipid Association
The NLA is a 501c(6) non-profit medical association that focuses on providing education, training, and resources on lipid management and the prevention of CVD to healthcare professionals. The NLA has been granted Accreditation with Commendation by the Accreditation Council for Continuing Medical Education (ACCME). The NLA is also a jointly accredited provider by the Accreditation Council for Pharmacy Education (ACPE), American Nurses Credentialing Center (ANCC), and the Commission on Dietetic Registration (CDR). NLA CME/CE activities have engaged nearly 50,000 participants and readers who have earned more than 15,000 CME/CE certificates to date.

Megan Cater, PlatformQ Health, http://www.platformqhealth.com, +1 (617) 938-6031, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.